Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients (Q80341009)
Jump to navigation
Jump to search
scientific article published on 01 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients |
scientific article published on 01 July 2005 |
Statements
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients (English)
Nicole Feller
Marjolein A van der Pol
Taco Waaijman
Geert W D Weijers
Guus Westra
Gert J Ossenkoppele
Gerrit J Schuurhuis